ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
118.532,68
-1,33%
S&P 500
5.942,47
1,26%
US Dollar vs BRL
6,1822
0,00%
Bitcoin
98.370,00
0,06%
Brent Oil
76,355
-0,20%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cytokinetics Inc (CYTK)

  7. Cytokinetics Inc (CYTK) Notícias

CYTK

Cytokinetics (CYTK)

Cytokinetics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYTK
DataHoraFonteTítuloCódigoCompanhia
03/01/202518:00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:CYTKCytokinetics Inc
23/12/202409:30GlobeNewswire Inc.Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic CardiomyopathyNASDAQ:CYTKCytokinetics Inc
20/12/202402:00GlobeNewswire Inc.Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater ChinaNASDAQ:CYTKCytokinetics Inc
16/12/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
16/12/202418:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CYTKCytokinetics Inc
16/12/202418:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CYTKCytokinetics Inc
03/12/202418:00GlobeNewswire Inc.Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CYTKCytokinetics Inc
03/12/202409:30GlobeNewswire Inc.Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection FractionNASDAQ:CYTKCytokinetics Inc
02/12/202418:00GlobeNewswire Inc.Cytokinetics to Participate in December Investor ConferencesNASDAQ:CYTKCytokinetics Inc
02/12/202409:30GlobeNewswire Inc.Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic CardiomyopathyNASDAQ:CYTKCytokinetics Inc
19/11/202404:30GlobeNewswire Inc.Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in JapanNASDAQ:CYTKCytokinetics Inc
16/11/202411:00GlobeNewswire Inc.Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024NASDAQ:CYTKCytokinetics Inc
16/11/202411:00GlobeNewswire Inc.Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024NASDAQ:CYTKCytokinetics Inc
14/11/202415:28Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CYTKCytokinetics Inc
12/11/202418:00GlobeNewswire Inc.Cytokinetics to Participate in the 2024 Jefferies London Healthcare ConferenceNASDAQ:CYTKCytokinetics Inc
12/11/202413:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CYTKCytokinetics Inc
11/11/202409:30GlobeNewswire Inc.Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089NASDAQ:CYTKCytokinetics Inc
07/11/202418:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CYTKCytokinetics Inc
06/11/202418:00GlobeNewswire Inc.Cytokinetics Reports Third Quarter 2024 Financial ResultsNASDAQ:CYTKCytokinetics Inc
05/11/202418:00GlobeNewswire Inc.Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024NASDAQ:CYTKCytokinetics Inc
23/10/202417:00GlobeNewswire Inc.Cytokinetics to Announce Third Quarter Results on November 6, 2024NASDAQ:CYTKCytokinetics Inc
16/10/202408:30GlobeNewswire Inc.Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst DayNASDAQ:CYTKCytokinetics Inc
02/10/202417:00GlobeNewswire Inc.Cytokinetics to Host Investor & Analyst Day on October 16, 2024NASDAQ:CYTKCytokinetics Inc
30/09/202410:20GlobeNewswire Inc.Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific MeetingNASDAQ:CYTKCytokinetics Inc
27/09/202412:00GlobeNewswire Inc.Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific SessionsNASDAQ:CYTKCytokinetics Inc
24/09/202408:30GlobeNewswire Inc.Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant ProgramNASDAQ:CYTKCytokinetics Inc
19/09/202417:00GlobeNewswire Inc.Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific MeetingNASDAQ:CYTKCytokinetics Inc
09/09/202408:30GlobeNewswire Inc.Cytokinetics Announces Data From Phase 1 Study of CK-4021586NASDAQ:CYTKCytokinetics Inc
05/09/202417:00GlobeNewswire Inc.Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual MeetingNASDAQ:CYTKCytokinetics Inc
01/09/202405:27GlobeNewswire Inc.Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024NASDAQ:CYTKCytokinetics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CYTK

Seu Histórico Recente

NYSE
PBR
Petroleo Brasileiro ADR
BOV
IBOV
Índice Bovespa
NYSE
RIO
Rio Tinto
BOV
VALE3
VALE ON
BOV
PETR4
PETROBRAS PN
BMF
INDFUT
BOV
GGBR4
GERDAU PN
FX
USDBRL
US Dollar vs BRL
COIN
BTCUSD
Bitcoin
CCOM
OILBRENT
Brent Oil
DBI
DAX
DAX
FX
EURBRL
Euro vs BRL
CCOM
OILCRUDE
Crude Oil
CCOM
US500
US 500
BOV
GFSA3
GAFISA ON
BOV
BBAS3
BANCO DO BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados